Flputnam Investment Management Co. Purchases Shares of 70,728 Cardinal Health, Inc. $CAH

Key Points

• Flputnam Investment Management purchased 70,728 Cardinal Health shares in the second quarter, valued at approximately $16.8 million. Institutional investors and hedge funds collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, exceeding estimates of $2.42, while revenue rose 5.8% year over year to $63.67 billion. The company guided to fiscal 2027 EPS of $12.40–$12.60.
• Analysts maintain a favorable outlook, with a “Moderate Buy” consensus rating and an average price target of $265.93 versus the stock’s reported price of $234.92. Cardinal Health also declared a quarterly dividend of $0.5158 per share.

Flputnam Investment Management Co. purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 70,728 shares of the company's stock, valued at approximately $16,802,000.

Several other institutional investors and hedge funds have also made changes to their positions in CAH. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Cardinal Health during the 4th quarter worth about $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health in the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp increased its stake in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Palladiem LLC acquired a new stake in Cardinal Health during the fourth quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co acquired a new stake in Cardinal Health during the first quarter worth approximately $29,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.1%

Shares of CAH opened at $234.92 on Monday. The firm has a market cap of $54.64 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. The company's 50 day simple moving average is $230.30 and its 200-day simple moving average is $217.19. Cardinal Health, Inc. has a 12-month low of $145.87 and a 12-month high of $258.30.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health's payout ratio is currently 28.49%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CAH shares. TD Cowen boosted their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a "buy" rating in a research report on Thursday. Weiss Ratings upgraded shares of Cardinal Health from a "buy (b)" rating to a "buy (b+)" rating in a research note on Wednesday, August 5th. Leerink Partners set a $292.00 price target on shares of Cardinal Health in a research report on Tuesday, August 11th. William Blair began coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an "outperform" rating for the company. Finally, Mizuho raised their price objective on Cardinal Health from $240.00 to $250.00 and gave the stock an "outperform" rating in a report on Wednesday. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and an average target price of $265.93.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source